ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 36 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $665,787 | +1413.2% | 67,048 | +511.5% | 0.00% | – |
Q2 2022 | $44,000 | -65.1% | 10,964 | -61.2% | 0.00% | -100.0% |
Q1 2022 | $126,000 | -69.0% | 28,292 | -72.1% | 0.00% | 0.0% |
Q4 2021 | $406,000 | +2.5% | 101,479 | +124.9% | 0.00% | 0.0% |
Q3 2021 | $396,000 | +91.3% | 45,127 | +147.0% | 0.00% | 0.0% |
Q2 2021 | $207,000 | -29.1% | 18,269 | -53.6% | 0.00% | -75.0% |
Q3 2020 | $292,000 | -52.0% | 39,349 | -73.0% | 0.00% | -60.0% |
Q2 2020 | $608,000 | +710.7% | 145,690 | +377.5% | 0.01% | +400.0% |
Q1 2020 | $75,000 | -76.9% | 30,508 | -50.6% | 0.00% | -33.3% |
Q3 2019 | $325,000 | -56.3% | 61,695 | -50.3% | 0.00% | -57.1% |
Q2 2019 | $744,000 | +9.4% | 124,038 | +64.7% | 0.01% | 0.0% |
Q1 2019 | $680,000 | +20.1% | 75,304 | +10.4% | 0.01% | 0.0% |
Q4 2018 | $566,000 | +251.6% | 68,205 | +482.9% | 0.01% | +250.0% |
Q3 2018 | $161,000 | +1.3% | 11,700 | -47.0% | 0.00% | -33.3% |
Q3 2017 | $159,000 | – | 22,070 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 484,096 | $6,317,000 | 5.34% |
CVI Holdings, LLC | 200,000 | $2,760,000 | 4.56% |
Mesirow Financial Investment Management, Inc. | 38,097 | $526,000 | 2.71% |
SPHERA FUNDS MANAGEMENT LTD. | 1,142,089 | $15,761,000 | 1.81% |
683 Capital Management, LLC | 1,350,000 | $18,630,000 | 1.21% |
Stonepine Capital Management, LLC | 145,000 | $2,001,000 | 1.17% |
Perceptive Advisors | 3,085,458 | $42,579,000 | 1.14% |
EAM Investors, LLC | 312,092 | $4,307,000 | 0.64% |
MANGROVE PARTNERS IM, LLC | 707,746 | $9,767,000 | 0.62% |
EAM Global Investors LLC | 86,614 | $1,195,000 | 0.48% |